Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • INVASIVE CANDIDA INFECTIONS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES AND HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: CURRENT EPIDEMIOLOGY AND THERAPEUTIC OPTIONS.

    Corrado Girmenia, Erica Finolezzi, Vincenzo Federico
    e2011013
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.013
    2297
    PDF: 982
    HTML: 1859
  • Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited

    IOANNIS KOTSIANIDIS
    e2019045
    2019-06-25
    https://doi.org/10.4084/mjhid.2019.045
    1106
    PDF: 862
    HTML: 253
  • IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?

    Giuseppe Gritti, Chiara Pavoni, Alessandro Rambaldi
    e2017010
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.010
    3408
    PDF: 1300
    HTML: 2231
    Fi.1 Gritti.Rambaldi: 210
  • EPSTEIN-BARR VIRUS RELATED LYMPHOPROLIFERATIONS AFTER STEM CELL TRANSPLANTATION

    Simona Sica, Elisabetta Metafuni, Silvia Bellesi, Patrizia Chiusolo
    e2009019
    2009-12-14
    https://doi.org/10.4084/mjhid.2009.019
    1376
    PDF: 573
    HTML: 2997
  • A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab

    Mauro Passucci, Francesca Fazio, Maria Teresa Petrucci
    e2023012
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.012
    908
    PDF: 960
    HTML: 417
  • PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL P53 EXPRESSION IN BONE MARROW BIOPSY IN HIGHER RISK MDS: A PILOT STUDY

    Alfredo Molteni, Emanuele Ravano, Marta Riva, Michele Nichelatti, Laura Bandiera, Lara Crucitti, Mauro Truini, Roberto Cairoli
    e2019015
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.015
    1876
    PDF: 988
    HTML: 333
  • Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma

    Muzaffer Keklik, Serdar Sivgin, Cigdem Pala, Celalettin Eroglu, Gulsah Akyol, Leylagul Kaynar, Mustafa Yavuz Koker, Demet Camlica, Ali Unal, Mustafa Cetin, Bulent Eser
    e2012063
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.063
    1456
    PDF: 735
    HTML: 4566
    Figure 1: Chest radiograph: 219
    Figure 2: Flow cytometer analysis of pleural fluid: 189
  • ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY

    Eldad J Dann
    e2014063
    2014-09-05
    https://doi.org/10.4084/mjhid.2014.063
    2154
    PDF: 1332
    HTML: 3506
  • Direct oral anticoagulants (DOACs) in the onco-hematologic patients

    Mario Biglietto, Silvio Ligia, Alessandro Laganà, Giovanni Manfredi Assanto, Martina Gherardini, Erminia Baldacci, Cristina Santoro, Antonio Chistolini
    e2025022
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.022
    1040
    PDF: 1026
    HTML: 123
  • Seven-Year Course of Hypoplastic Myelodysplastic Syndrome Unmasked by Secondary and Neurosyphilis.

    Ali Turunç, Hüseyin Derya Dinçyürek, Birol Güvenç
    e2026026
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.026
    511
    PDF: 357
    HTML: 173
  • Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases

    Mariam Markouli, Panagiotis Diamantopoulos, Asimenia Halioti, Stavroula Lontou, Marina Mantzourani
    e2026006
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.006
    853
    PDF: 635
    Suppl. Files: 124
    HTML: 101
  • The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients

    Hesham Elsabah, Mahmood B. Aldabt, Ruba Taha, Dina Sameh Soliman, Halima Elomri, Feryal Ibrahim
    e2020082
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.082
    1010
    PDF: 369
    HTML: 208
  • POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

    Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles
    e2010016
    2010-06-19
    https://doi.org/10.4084/mjhid.2010.016
    1192
    PDF: 769
    HTML: 587
  • BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE

    Michele Malagola
    e2017036
    2017-06-20
    https://doi.org/10.4084/mjhid.2017.036
    2449
    PDF: 841
    HTML: 1068
  • COVID-19 post hematopoietic cell transplant, a report of 11 cases from a single center.

    Afadil Adam
    e2020070
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.070
    1736
    PDF: 1139
    HTML: 295
  • Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19

    Fehmi Hindilerden, Ipek Yonal-Hindilerden, Emre Akar, Zuhal Yesilbag, Kadriye Kart-Yasar
    e2020053
    2020-09-14
    https://doi.org/10.4084/mjhid.2020.053
    3271
    PDF: 1592
    HTML: 267
  • CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

    Luca Castagna, Carmelo Carlo-Stella, Rita Mazza, Armando Santoro
    e2015015
    2015-02-12
    https://doi.org/10.4084/mjhid.2015.015
    2817
    PDF: 1428
    HTML: 4630
  • AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS

    Giuseppe Visani, Paola Picardi, Patrizia Tosi, Alessandro Isidori
    e2012075
    2012-11-07
    https://doi.org/10.4084/mjhid.2012.075
    2607
    PDF: 880
    HTML: 2126
  • OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONINIG REGIMEN IN PATIENTS WITH IDIOPATHIC MYELOFIBROSIS: THE G.I.T.M.O. EXPERIENCE AND REVIEW OF THE LITERATURE

    Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, Miriam Isola, Maria Teresa Van Lint, Anna Paola Iori, Paolo Di Bartolomeo, Maurizio Musso, Pietro Pioltelli, Giuseppe Visani, Pasquale Iacopino, Renato Fanin, Alberto Bosi
    e2010010
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.010
    1546
    PDF: 797
    HTML: 771
  • BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

    Giuseppe Leone, Eligio Pizzigallo
    e2015057
    2015-10-12
    https://doi.org/10.4084/mjhid.2015.057
    4941
    PDF: 1990
    HTML: 8418
  • APLASTIC ANEMIA AND VIRAL HEPATITIS

    Laura Cudillo
    e2009026
    https://doi.org/10.4084/mjhid.2009.026
    1280
    PDF: 533
    HTML: 23090
  • DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE.

    Mariagiovanna Cefalo, Ermanno Puxeddu, Loredana Sarmati, giovangiacinto paterno, Carla Fontana, Daniela Nassa, Gloria Pane, Eleonora De Bellis, Raffaele Palmieri, Elisa Buzzatti, Federico Meconi, Roberta Laureana, Paola Casciani, Anna Giulia Zizzari, Paola Rogliani, Paolo de Fabritiis, Luca Maurillo, Francesco Buccisano, Maria Cantonetti, William Arcese, Adriano Venditti, Maria Ilaria Del Principe
    e2019065
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.065
    1365
    PDF: 1015
    HTML: 273
  • Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disease

    Giacomo Andreani, Gianluca Fadda, Dario Gned, Matteo Dragani, Giovanni Cavallo, Valentina Monticone, Alessandro Morotti, Marco De Gobbi, Angelo Guerrasio, Antonio D'Avolio, Daniela Cilloni
    e2019061
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.061
    1442
    PDF: 1096
    HTML: 199
  • COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

    Jean Elcheikh
    e2015048
    2015-08-21
    https://doi.org/10.4084/mjhid.2015.048
    1929
    PDF: 1025
    HTML: 1355
  • CLINICAL USEFULNESS OF BROCHOALVEOLAR LAVAGE IN THE MANAGEMENT OF PULMONARY INFILTRATES IN ADULTS WITH HAEMATOLOGICAL MALIGNANCIES AND STEM CELL TRANSPLANTATION

    Laura Jorge, Diego Torres, Agustín Languasco, Pablo Rodriguez, Pablo Bonvehí, Elena Temporiti, Silvia Relloso, Cristina Videla, Fabián Herrera
    e2020025
    2020-05-01
    https://doi.org/10.4084/mjhid.2020.025
    8149
    PDF: 790
    HTML: 226
  • BING-NEEL SYNDROME: ILLUSTRATIVE CASES AND COMPREHENSIVE REVIEW OF THE LITERATURE

    Marzia Varettoni, Irene Defrancesco, Luca Diamanti, Enrico Marchioni, Lisa Maria Farina, Anna Pichiecchio
    e2017061
    2017-10-18
    https://doi.org/10.4084/mjhid.2017.061
    3498
    PDF: 1512
    HTML: 1322
  • CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment

    Ugo Testa, Elvira Pelosi, Dr. Germana Castelli
    e2024077
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.077
    1762
    PDF: 859
    HTML: 153
  • OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

    Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz
    e2012011
    2012-02-10
    https://doi.org/10.4084/mjhid.2012.011
    1133
    PDF: 550
    HTML: 1699
    Figures: 175
    Fifures Sanz: 181
    tables Sanz: 184
    Untitled: 183
  • Addition of daratumumab to first-line therapy of newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation: a single-center real-life experience

    Edoardo Olivari
    e2025040
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.040
    1067
    PDF: 782
    HTML: 156
  • Cytokine release syndrome after haploidentical transplantation is associated with improved survival without increasing transplant-related mortality

    Daniele Avenoso, Natalia Difrancesco, Enrico Morello, Gabriele Magliano, Mirko Farina, Vera Radici, Simone Bernardi, Alessandro Leoni, Federica Re, Shreyas Hanmantgad, Domenico Russo, Michele Malagola
    e2026059
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.059
    106
    PDF: 74
    HTML: 5
  • GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Laura Breda, Roberto Gambari, Stefano Rivella
    e2009008
    2009-11-16
    1300
    PDF: 428
    HTML: 2887
  • POEMS SYNDROME: AN UPDATE

    Andrea Nozza
    e2017051
    2017-09-01
    https://doi.org/10.4084/mjhid.2017.051
    3377
    PDF: 1663
    HTML: 1525
  • TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment

    Alessandro Buonomo, Eleonora Nucera, Marianna Criscuolo
    e2022040
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.040
    2145
    PDF: 1552
    HTML: 513
  • Impact of Donor-Specific anti-HLA antibodies and donor KIR characteristics in haploidentical HSCT for beta-Thalassemia

    Marco Andreani, Manuela Testi, Pietro Sodani, Maria Troiano, Andrea Di Luzio, Giuseppe Testa, Michela Falco, Elvira Poggi, Javid Gaziev, Antonina Piazza
    e2017020
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.020
    2993
    PDF: 977
    HTML: 533
  • TREOSULFAN-BASED CONDITIONING REGIMEN IN SIBLING AND ALTERNATIVE DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH SICKLE CELL DISEASE

    Antonio Marzollo, Elisabetta Calore, Manuela Tumino, Marta Pillon, Maria Vittoria Gazzola, Roberta Destro, Raffaella Colombatti, Piero Marson, Tiziana Tison, Anna Colpo, Chiara Mainardi, Maria Gabelli, Maria Paola Boaro, Sara Rossin, Aurora Strano, Nadia Quaglia, Federica Menzato, Giuseppe Basso, Laura Sainati, Chiara Messina
    e2017014
    2017-02-15
    https://doi.org/10.4084/mjhid.2017.014
    4330
    PDF: 1532
    HTML: 1193
  • Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

    Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda
    e2025026
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.026
    1982
    PDF: 1670
    HTML: 133
  • SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW

    Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca
    e2016062
    2016-11-06
    https://doi.org/10.4084/mjhid.2016.062
    3787
    PDF: 1076
    HTML: 2066
  • POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE

    Daniela Capello, Gianluca Gaidano
    e2009018
    https://doi.org/10.4084/mjhid.2009.018
    1320
    PDF: 477
    HTML: 18616
    Figure 1: 174
    Figure 2: 154
    Figure 3: 171
    Figure 4: 210
    Figure 5: 182
  • Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia

    Jérôme Guison, Gilles Blaison, Oana Stoica, Remy Hurstel, Marie Favier, Remi Favier
    e2017038
    2017-06-16
    https://doi.org/10.4084/mjhid.2017.038
    2165
    PDF: 845
    HTML: 932
    Patient’s family tree: 173
  • Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation and or Treated with Immunomodulatory Agents

    Alhossain A. Khalafallah, Matthias Maiwald, Amanda Cox, Burns Denise, Gerald Bates, Terry Hannan, David Seaton, Bernadene Fernandopulle, Terry Brain
    e2010005
    2010-04-20
    https://doi.org/10.4084/mjhid.2010.005
    1165
    PDF: 578
    HTML: 1148
  • INFECTIOUS AETIOLOGY OF MARGINAL ZONE LYMPHOMA AND ROLE OF ANTI-INFECTIVE THERAPY

    Salvatore Perrone, Gianna Maria D'Elia, Alessandro Pulsoni
    e2016006
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.006
    4473
    PDF: 1338
    HTML: 2165
  • THERAPEUTIC TARGETING OF NOTCH SIGNALING PATHWAY IN HEMATOLOGICAL MALIGNANCIES

    Giovanni Roti, Claudia Sorrentino, Antonio Cuneo
    e2019037
    2019-06-25
    https://doi.org/10.4084/mjhid.2019.037
    2128
    PDF: 1608
    HTML: 603
  • Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient

    Poorvi Chordia, Pranatharthi H Chandrasekar
    e2014008
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.008
    1201
    PDF: 839
    HTML: 2188
    Figue 1: 178
  • Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)

    Eugenio Galli, Silvia Bellesi, Marcello Viscovo, Federica Sorà, Stefan Hohaus, Nicola Piccirillo, Luca Laurenti, Patrizia Chiusolo, Valerio De Stefano, Simona Sica, Gina Zini
    e2021066
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.066
    1255
    PDF: 546
    HTML: 231
  • THE ROLE OF CORTICOSTEROIDS IN ADULT RESPIRATORY DISTRESS SYNDROME CAUSED BY VIRIDANS GROUP STREPTOCOCCI BACTEREMIA IN NEUTROPENIC PATIENTS

    Abraham Tareq Yacoub, Lysenia Mojica, Lily Jones, Andrea Knab, Sally Alrabaa, John Norman Greene
    e2014055
    2014-09-01
    https://doi.org/10.4084/mjhid.2014.055
    2137
    PDF: 880
    HTML: 1861
    Table: 236
  • TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY

    Agustin Avilès, Maria-Jesus Nambo, Natividad Neri
    e2018006
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.006
    3592
    PDF: 1086
    HTML: 880
  • OUTCOMES OF OVERT AND NON-OVERT DISSEMINATED INTRAVASCULAR COAGULATION USING THE ISTH DIC SCORING SYSTEM IN CHILDREN: A SINGLE-CENTER STUDY

    Jassada Buaboonnam, Chonthida Wnagkittikal, Nattee Narkbunnam, Nassawee Vathana, Chayamon Takpradit, Kamon Phuakpet, Phakatip Sinlapamongkolkul, Kleebsabai Sanpakit, Khemajira Karaketklang, Bunchoo Pongtanakul
    e2023004
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.004
    1272
    PDF: 1141
    HTML: 636
  • DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE

    Paola Zanotti, Claudia Chirico, Maurizio Gulletta, Laura Ardighieri, Salvatore Casari, Eugenia Quiros Roldan, Ilaria Izzo, Gabriele Pinsi, Giovanni Lorenzin, Fabio Facchetti, Francesco Castelli, Emanuele Focà
    e2018040
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.040
    3721
    PDF: 1309
    HTML: 746
    Figure 2: 459
    Figure 1: 3128
  • How I treat acute and persistent sickle cell pain

    Samir Ballas
    e2020064
    2020-09-08
    https://doi.org/10.4084/mjhid.2020.064
    1980
    PDF: 1126
    HTML: 492
  • WHAT ARE FUNGAL INFECTIONS?

    Ben E de Pauw
    e2011001
    2011-01-03
    https://doi.org/10.4084/mjhid.2011.001
    4252
    PDF: 2422
    HTML: 27634
    de Pauw: 244
151 - 200 of 220 items << < 1 2 3 4 5 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.